These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15738447)

  • 1. Summaries for patients. Does hepatitis B vaccination protection continue after 15 years?
    Ann Intern Med; 2005 Mar; 142(5):I34. PubMed ID: 15738447
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
    McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
    Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years.
    Chen DS
    Ann Intern Med; 2005 Mar; 142(5):384-5. PubMed ID: 15738458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 8. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization of hepatitis B infection by a 25-year universal vaccination program.
    Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
    J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
    Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
    Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post vaccination status in health care workers.
    Loomba PS; Thakur A; Mishra B; Dogra V
    J Commun Dis; 2007 Sep; 39(3):205-7. PubMed ID: 18697588
    [No Abstract]   [Full Text] [Related]  

  • 13. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.
    Aghakhani A; Mohraz M; Aghasadeghi MR; Banifazl M; Vahabpour R; Karami A; Foroughi M; Ramezani A
    Int J STD AIDS; 2016 Oct; 27(11):967-72. PubMed ID: 26384943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan.
    Rezaei M; Nooripoor S; Ghorbani R; Ramezanshams F; Mamishi S; Mahmoudi S
    J Prev Med Hyg; 2014 Mar; 55(1):1-3. PubMed ID: 25916024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success of mass vaccination of infants against hepatitis B.
    Durand AM; Sabino H; Mahoney F
    JAMA; 1996 Dec; 276(22):1802-3. PubMed ID: 8946897
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis B--the current situation.
    Jilg W; Deinhardt F
    Infection; 1986; 14(3):100-1. PubMed ID: 2942487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.